期刊文献+

高脂血症与IgA肾病临床病理的相关性分析 被引量:8

The Relationship between Hyperlipidemia and Clinic Pathology of IgA Nephropathy
下载PDF
导出
摘要 目的探讨高脂血症与IgA肾病临床病理的相关性。方法选取IgA肾病患者70例,根据血脂水平分为非高脂血症组(n=45)和高脂血症组(n=25),并对两组年龄、收缩压、舒张压、临床指标及病理情况进行比较。结果2组患者性别、血压等指标差异均无统计学意义(P均〉0.05)。2组患者血肌酐、尿素氮、血尿酸及24h尿蛋白定量差异均有统计学意义(P均〈0.05)。高脂血症组IgA肾病病理损害重于非高脂血症组(P〈0.05),肾小球硬化、肾小管间质病变程度和血管病变发生率较高、较重(P均〈0.05)。结论伴有高脂血症的IgA肾病患者血尿酸较高、24h尿蛋白量大,肾功能较差,病理损害较重,预后较差。 Objective To analyze the correlation between the level of serum lipid levels and the clinical and pathological features of IgA nephropathy.Methods 70 patients diagnosed as IgA nephropathy by renal biopsy in our hospital were divided into hyperlipidemia group(25 cases)and non-hyperlipidemia group(45 cases) according to the level of serum lipid.The clinical parameters and renal pathology grade were compared.Results There were significant differences between hyperlipidemia group and non-hyperlipidemia group in the incidences of the blood urea nitrogen(BUN),creatinine(Cr),uric acid and 24 hour urine protein amount(all P 〈 0.05),while no differences in age,systolic pressure and diastolic pressure.Compared with non-hyperlipidaemia group,the pathological injury was severer in hyperlipidaemia group(P 〈 0.05).The incidence of glomerular sclerosis,vascular injury, interstitial lesion and crescent was higher in hyperlipidaemia group(all P 〈 0.05).Conclusions Compared with non-hyperlipidaemia patients, BUN,Cr, uric acid and 24 hour urine protein 1 evels were higher, the renal function,pathological injury and prognosis were worse in IgA nephropathy patients associated with hyperlipidaemia.
作者 沈姗 柴华旗
出处 《中国血液流变学杂志》 CAS 2013年第2期268-270,273,共4页 Chinese Journal of Hemorheology
关键词 高脂血症 肾小球肾炎 IGA 临床病理学 hyperlipidaemia glomerulonephritis,IgA pathology, clinical
  • 相关文献

参考文献10

  • 1Coppo R,D'Amico G.Factors predicting progression of IgA nephropathies[J].J Nephrol,2005,18(5):503 - 512.
  • 2Syrj-tnen J,Mustonen J,Pasternack A.Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy[J].Nephrol Dial Transplant,2000,15(1): 34 - 42.
  • 3Katafuchi R,Kiyoshi Y, Oh Y, et al.Glomerular score as a prognosticator in IgA nephropathy:its usefulness and limitation[J]. Clin Nephrol, 1998,49(1 ): 1 - 8.
  • 4Abrass CK.Cellular lipid metabolism and the role of lipids in progressive renal disease[J].Am J Nephrol,2004,24(1): 46 - 53.
  • 5Spencer MW, Muhlfeld AS,Segerer S,et al.Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice[J].Am J Nephrol,2004,24(1):20 - 31.
  • 6Iwasa Y, Otsubo S,Ishizuka T, et al.Influence of serum high-molecular-weight and total adiponectin on arteriosclerosis in IgA nephropathy patients[J].Nephron Clin Pract,2008,108(3):c226 - c232.
  • 7Rauta V, Finne P, Fagerudd J,et al.Factors associated with progression of IgA nephropathy are related to renal function a model for estimating risk of progression in mild disease[J]. Clin Nephrol,2002,58(2):85 - 94.
  • 8Nakamura T,Ushiyama C,Hirokawa K,et al.Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis[J].Nephrol Dial Transplant,2002,17(5):798 - 802.
  • 9Joles JA,Kunter U,Janssen U,et al.Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats[J].J Am Soc Nephrol,2000,11 (4):669 - 683.
  • 10朱文华,陈蕾倩,方力争,钱贞英,陈彦.高尿酸血症与血脂、肥胖相关因素分析[J].浙江预防医学,2004,16(12):70-70. 被引量:33

二级参考文献6

共引文献32

同被引文献41

  • 1殷玥琪,杨立刚,孙桂菊.高脂血症与高血压相关性及其代谢异常研究进展[J].中国老年学杂志,2014,34(5):1414-1417. 被引量:22
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5222
  • 3郭增玉,刘国华,李航.IgA肾病合并肥胖的临床病理分析[J].中国临床医生杂志,2007,35(7):39-41. 被引量:4
  • 4Le W, Liang S, Hu Y, et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population[J]. Nephrol Dial Transplant, 2012, 27(4): 1479-1485.
  • 5Li X, Liu Y, Lv J, et al. Progression ofIgA nvphropathy under current therapy regimen in a Chinese population[J]. Clin J Am Soc Nephrol, 2014, 9(3): 484-489.
  • 6Syrjanen J, Mustonen J, Pasternack A. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy[J]. Nephrol Dial Transplant, 2000, 15(1): 34-42.
  • 7Katzir Z, Leibovitch E, Vaknin H, et al. Effect of atorvastatin on IgA nc'phropathy in the rat[J]. Clin Nephrol, 2013, 79(3): 214-220.
  • 8Moriyama T, Oshima Y, Tanaka K, et al. Statins stabilize the renal function of IgA nvphropathy[J]. Rcn Fail, 2014, 36(3): 356-360.
  • 9Tanaka S, Ninomiya T, Katafuchi R, et al. Development and validation of a prediction role using the Oxford classification in IgA nephropathy[J]. Clin J Am Soc Nephrol, 2013, 8(12): 2082-2090.
  • 10Kramer S, Kron S, Wang-Rosenke Y, et al. Rosuvastatin is additive to high-dose candesattau in slowing progression of experimental mesangioproliferative glomerulosclerosis[J]. Am J Physiol Renal Physiol, 2008, 294(4): F801-F811.

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部